Heterogeneity of IL-15-expressing mesenchymal stromal cells controls natural killer cell development and immune cell homeostasis

C Carmen Stecher (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center) R Romana Bischl A Anna Schmid-Böse S Stefanie Ferstl E Elisabeth Potzmann M Magdalena Frank N Nina Braun (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center) M Matthias Farlik (Department of Dermatology, Medical University of Vienna) R Richard A. Flavell (Department of Immunobiology, Yale School of Medicine) D Dietmar Herndler-Brandstetter (Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center)

Abstract

Abstract Bone marrow (BM) mesenchymal stromal cells (MSC) provide microenvironmental niches that support hematopoietic stem cells and regulate hematopoiesis. Whether functional heterogeneity among BM MSCs contributes to the development and survival of distinct immune cell lineages remains incompletely understood. Here, we use an Il15 knockin reporter and multiple conditional deletion mouse models to show distinct differences in IL-15 expression between BM MSC subtypes. Conditional deletion of Il15 in Osx + stromal cells results in decreased natural killer (NK) cell precursors, memory CD8+ T cells and NKT cells but not mature NK cells. Lepr + stromal cells support the survival of mature NK cells and memory CD8+ T cells in the BM of older mice, while endothelial cells support mature NK cells and memory CD8+ T cells in the blood but not in the BM. Thus, our data suggest that MSC subtypes differentially regulate the development and survival of IL-15-dependent immune cell lineages in the BM.

Article Details

Volume / Issue Vol. 16, Issue 1
Published July 01, 2025
ISSN 2041-1723
Publisher Nature Portfolio

Journal Info

Nature Communications

Nature Portfolio

ISSN: 2041-1723 Open Access Life Sciences

Authors (10)

C

Carmen Stecher

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center

R

Romana Bischl

A

Anna Schmid-Böse

S

Stefanie Ferstl

E

Elisabeth Potzmann

M

Magdalena Frank

N

Nina Braun

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center

M

Matthias Farlik

Department of Dermatology, Medical University of Vienna

R

Richard A. Flavell

Department of Immunobiology, Yale School of Medicine

D

Dietmar Herndler-Brandstetter

Center for Cancer Research, Medical University of Vienna and Comprehensive Cancer Center